Kringle Pharma, Inc. (TYO:4884)
Japan · Delayed Price · Currency is JPY 597.00
-14.00 (-2.29%)
Oct 26, 2026, 3:30 PM JST
Kringle Pharma Market Cap
Kringle Pharma has a market cap or net worth of 5 billion as of October 26, 2026. It is the 33,459th most valuable company in the world and the 3,074th biggest in Japan. Its market cap has increased by 62.67% in one year.
Market Cap
5.00B
Enterprise Value
3.94B
Revenue
342.21M
Global Rank
Country Rank
#3,074 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 28, 2020, Kringle Pharma's market cap has decreased from 5.09B to 5.00B, a decrease of -1.60%. That is a compound annual growth rate of -0.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 5.00B | 77.16% |
| Dec 30, 2025 | 2.82B | -52.49% |
| Dec 30, 2024 | 5.95B | 30.66% |
| Dec 29, 2023 | 4.55B | 47.85% |
| Dec 30, 2022 | 3.08B | -0.04% |
| Dec 30, 2021 | 3.08B | -45.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ADR Biomedical Holdings | 6.68B |
| MEDINET | 6.24B |
| CellSource | 6.21B |
| TMS Co., Ltd. | 6.03B |
| SUSMED,Inc. | 5.83B |
| Soiken Holdings | 5.68B |
| Cyfuse Biomedical K.K. | 5.67B |
| BrightPath Biotherapeutics | 5.42B |